Furthermore, TTFields induce the expression of immunogenic markers on cancer cells, including calreticulin (CRT) on the cell surface and the release of high mobility group box 1 protein (HMGB1), indicating immunogenic cell death. The gene discussed is CALR; the disease is cancer.